C07K 16/1246
Rickettsiales
Official title: Rickettsiales (O)
C07K16/1246 (Rickettsiales) appears on 54 US grants and 58 published applications in this corpus.
Search patents in C07K- Granted patents
- 54
- Published applications
- 58
- Assignees
- 28
- Inventors
- 64
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 2 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 4 |
| 2010 | 4 | 4 |
| 2011 | 2 | 4 |
| 2012 | 0 | 1 |
| 2013 | 3 | 0 |
| 2014 | 1 | 3 |
| 2015 | 2 | 3 |
| 2016 | 1 | 4 |
| 2017 | 8 | 5 |
| 2018 | 3 | 3 |
| 2019 | 4 | 4 |
| 2020 | 3 | 6 |
| 2021 | 3 | 3 |
| 2022 | 4 | 3 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 2 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ehrlichia vaccines and immunogenic compositions12 May 2026US 12,624,093 B2Research Development Foundation
- Ehrlichia ruminantium immunogenic compositions and methods of using thereof5 Aug 2025US 12,377,139 B2Kansas State University Research Foundation
- Chimeric vaccine antigens for anaplasmosis4 Mar 2025US 12,239,696 B2Virginia Commonwealth University
- Methods and compositions for diagnosis of rickettsia infection17 Sep 2024US 12,092,640 B2
- Intracellular nanobody targeting T4SS effector inhibits ehrlichia infection8 Nov 2022US 11,492,391 B1Ohio State Innovation Foundation
- Ehrlichia vaccines and immunogenic compositions20 Aug 2026US 2026/0242451 A1Research Development Foundation
- Cell-based method for determining an activity of botulinum toxin6 Feb 2025US 2025/0044281 A1Hugel Inc.
- Multiple de novo designed protein binding proteins14 Nov 2024US 2024/0376156 A1University of Washington
- Cell-based method for determining an activity of botulinum toxin7 Mar 2024US 2024/0077470 A1Hugel Inc.
- Ehrlichia vaccines and immunogenic compositions10 Nov 2022US 2022/0356231 A1Research Development Foundation
Most cited
By later US patents
- Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis36US 5,401,656 AUnited States of America · 1995
- Ehrlichia species from a patient suffering from ehrlichiosis35US 5,413,931 AUnited States of America · 1995
- Identification of a new Ehrlichia species from a patient suffering from Ehrlichiosis31US 5,789,176 AThe United States of America as represented by the Department of Health and Human Services · 1998
- Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis25US 5,989,848 AThe United States of America as represented by the Department of Health and Human Services · 1999
- Nucleic acid encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby13US 6,436,399 B1The Ohio State University Research Foundation · 2002